Chemokine Ligand 2 Genetic Variants, Serum Monocyte Chemoattractant Protein-1 Levels, and the Risk of Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.110.205526PMID 20431065PMCID PMC4210837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update

  2008cited by this paper
• Estimating Haplotype Effects on Dichotomous Outcome for Unphased Genotype Data Using a Weighted Penalized Log-Likelihood Approach

  2006cited by this paper
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

  2005cited by this paper
• Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.

  2005cited by this paper
• Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.

  2004cited by this paper
• Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele

  2004cited by this paper
• Short CommunicationThe MCP-1 Promoter -2518 Polymorphism in Behcet's Disease: Correlation Between Allele Types, MCP-1 Production and Clinical Symptoms among Korean Patients

  2004cited by this paper
• Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

  2004cited by this paper
• Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.

  2004cited by this paper
• Estimation of Multilocus Haplotype Effects Using Weighted Penalised Log‐Likelihood: Analysis of Five Sequence Variations at the Cholesteryl Ester Transfer Protein Gene Locus

  2003cited by this paper
• Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age

  2003cited by this paper
• Chemokine/chemokine receptor nomenclature

  2003cited by this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness.

  2003cited by this paper
• HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

  2002cited by this paper
• Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.

  2002cited by this paper
• Chemokine/chemokine receptor nomenclature.

  2002cited by this paper
• Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation.

  2001cited by this paper
• Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty

  2001cited by this paper
• Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.

  2001cited by this paper
• EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.

  1999cited by this paper
• Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.

  1997cited by this paper
• Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.

  1992cited by this paper
• Monocyte chemoattractant protein-1 in human atheromatous plaques.

  1991cited by this paper
• Guidelines and Guidance Strengthening the Reporting of Genetic Association Studies (strega)— an Extension of the Strobe Statement the Guidelines and Guidance Section Contains Advice on Conducting and Reporting Genotyping Errors Population Stratification

  year unknowncited by this paper

• Association of the CCL2 A/G (rs3760399) gene variant and its expression with COPD risk and response to combined budesonide/formoterol therapy

  2026cites this paper
• MCP-1 rs1024611 Polymorphism, MCP-1 Concentrations, and Premature Coronary Artery Disease: Results of the Genetics of Atherosclerotic Disease (GEA) Mexican Study

  2024cites this paper
• Association of CCL5 rs2107538, and CCL2 rs3760396 Gene Polymorphisms with the Risk of Cardiovascular Disease

  2021influential citation
• Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study

  2021cites this paper
• Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.

  2019cites this paper
• Association between MCP-1 A 2518 G polymorphism and coronary artery disease risk : evidence from 21 case-control studies

  2016cites this paper
• Association of Monocyte Chemoattractant Protein‐1 (MCP‐1)‐2518A>G Polymorphism with Susceptibility to Coronary Artery Disease: A Meta‐Analysis

  2015cites this paper
• Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.

  2015cites this paper
• Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease

  2015cites this paper
• Folic acid supplementation and biomarkers of progression of subclinical coronary atherosclerosis in patients with stable angina pectoris

  2014cites this paper
• The associations between the MCP-1 −2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals

  2014cites this paper
• Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis

  2013cites this paper
• Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.

  2012cites this paper
• Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility

  2012cites this paper
• The rs1024611 Regulatory Region Polymorphism Is Associated with CCL2 Allelic Expression Imbalance

  2012cites this paper
• The role of combined assessment of defense against oxidative stress and inflammation in the evaluation of peripheral arterial disease.

  2011cites this paper
• Systemic chemokine levels, coronary heart disease, and ischemic stroke events

  2011cites this paper
• Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis.

  2011cites this paper
• Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis

  2010cites this paper
• Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias

  2010cites this paper